Clinical updates, including trial initiations, enrollment status and data readouts and publications: Astellas, Avrobio, Biophytis, Cassava, City of Hope, Crescita, Cyclo, Da Volterra, Dermata, Elicio, Exelixis, Lidds, Moderna, NGM, Pfizer, Seattle Genetics, Sellas, Soligenix, T3D.